190 related articles for article (PubMed ID: 24333062)
21. Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis.
Kellner H; Zoller WG
Z Gastroenterol; 1992 Nov; 30(11):779-83. PubMed ID: 1471384
[TBL] [Abstract][Full Text] [Related]
22. Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies.
Rombout-Sestrienkova E; Brandts L; Koek GH; van Deursen CTBM
J Clin Apher; 2022 Feb; 37(1):100-105. PubMed ID: 34897777
[TBL] [Abstract][Full Text] [Related]
23. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.
Florkowski CM; George PM; Willis JA; Stott MK; Burt MJ; Upton JD; Nesbit J; Walmsley TA; Scott RS
Diabetes Res Clin Pract; 1999 Mar; 43(3):199-203. PubMed ID: 10369430
[TBL] [Abstract][Full Text] [Related]
24. [Elevated serum ferritin and hemochromatosis in general practice].
Mouland G; Bratland B; Hornnes MB; Asser HP; Lier J; Reiso H; Rygh E
Tidsskr Nor Laegeforen; 2005 Jan; 125(1):20-2. PubMed ID: 15643457
[TBL] [Abstract][Full Text] [Related]
25. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
26. The role of serum ferritin in the management of idiopathic haemochromatosis.
Batey RG; Hussein S; Sherlock S; Hoffbrand AV
Scand J Gastroenterol; 1978; 13(8):953-7. PubMed ID: 725519
[TBL] [Abstract][Full Text] [Related]
27. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians.
Schmitt B; Golub RM; Green R
Ann Intern Med; 2005 Oct; 143(7):522-36. PubMed ID: 16204165
[TBL] [Abstract][Full Text] [Related]
28. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis.
Milman N; Albeck MJ
Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826
[TBL] [Abstract][Full Text] [Related]
29. Haemochromatosis.
Adams PC; Barton JC
Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
[TBL] [Abstract][Full Text] [Related]
30. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
Milman N
Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
[TBL] [Abstract][Full Text] [Related]
31. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of hereditary hemochromatosis: an update.
Kanwar P; Kowdley KV
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
[TBL] [Abstract][Full Text] [Related]
33. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
[TBL] [Abstract][Full Text] [Related]
34. Haemochromatosis in a kidney transplant recipient: a case report.
Zakrocka I; Baranowicz-Gąszczyk I; Załuska W
BMC Nephrol; 2021 May; 22(1):201. PubMed ID: 34051741
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
[TBL] [Abstract][Full Text] [Related]
36. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.
Abraham D; Rogers J; Gault P; Kushner JP; McClain DA
Diabetologia; 2006 Nov; 49(11):2546-51. PubMed ID: 17019598
[TBL] [Abstract][Full Text] [Related]
37. Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes.
Mousavi SA; Mahmood F; Aandahl A; Knutsen TR; Llohn AH
Biomed Res Int; 2015; 2015():241784. PubMed ID: 26380265
[TBL] [Abstract][Full Text] [Related]
38. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
39. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
Verhaegh PL; Moris W; Koek GH; van Deursen CT
Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127
[TBL] [Abstract][Full Text] [Related]
40. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).
Ong SY; Dolling L; Dixon JL; Nicoll AJ; Gurrin LC; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Kava J; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
BMJ Open; 2015 Aug; 5(8):e008938. PubMed ID: 26270952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
